Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of KW-2246 for breakthrough cancer pain
jRCT2080221423Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Mar 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cancer pain comparing KW-2246 (fentanyl) with Placebo (2 arms).
02
Drugs
fentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080221423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221423.